Amination-mediated nano eye-drops with enhanced corneal permeability and effective burst release for acute glaucoma treatment - ScienceDirect

Self-assembled chitosan-sodium usnate drug delivery nanosystems: Synthesis, characterization, stability studies, in vitro cytotoxicity and in vivo biocompatibility against 143 B cells - ScienceDirect

Nanomedicines for the treatment of glaucoma: Current status and future perspectives - ScienceDirect

Lipid-based nanocarriers challenging the ocular biological barriers: Current paradigm and future perspectives - ScienceDirect

Hydroxypropyl methacrylamide-based copolymeric nanoparticles loaded with moxifloxacin as a mucoadhesive, cornea-penetrating nanomedicine eye drop with enhanced therapeutic benefits in bacterial keratitis - ScienceDirect

β-blocker eye drops affect ocular surface through β2 adrenoceptor of corneal limbal stem cells, BMC Ophthalmology

Self-assembled chitosan-sodium usnate drug delivery nanosystems: Synthesis, characterization, stability studies, in vitro cytotoxicity and in vivo biocompatibility against 143 B cells - ScienceDirect

PDF) Ocular Pharmacokinetics and Toxicity of Nanoparticular Acetazolamide: in vivo Distribution and safety of PHBV-ACZ Nanoparticle

Lipid-based nanocarriers challenging the ocular biological barriers: Current paradigm and future perspectives - ScienceDirect

Nanoparticles for the treatment of glaucoma-associated neuroinflammation, Eye and Vision

Magic Bullets: The Coming Age of Meaningful Pharmacological Control of the Corneal Responses to Injury and Disease

Nanomaterial-based ophthalmic drug delivery - ScienceDirect

Pharmaceutics, Free Full-Text

Intraocular nano-microscale drug delivery systems for glaucoma treatment: design strategies and recent progress, Journal of Nanobiotechnology

Self-assembled chitosan-sodium usnate drug delivery nanosystems: Synthesis, characterization, stability studies, in vitro cytotoxicity and in vivo biocompatibility against 143 B cells - ScienceDirect

Electrosprayed core-shell nanoparticles for sustained release fixed combination monotherapy in glaucoma treatment - ScienceDirect